Works by Lin, Ching-Hung


Results: 70
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Anti-tumor efficacy of a bevacizumab preconditioning followed by etoposide and cisplatin regimen in human epidermal growth factor receptor-2-positive breast cancer brain metastasis refractory to whole brain radiotherapy.

    Published in:
    Journal of Cancer Research & Practice, 2023, v. 10, n. 1, p. 11, doi. 10.4103/ejcrp.eJCRP-D-23-00001
    By:
    • Chen, Tom;
    • Lin, Ching-Hung;
    • Yeh, Dah-Cherng;
    • Tseng, Ling-Ming;
    • Rau, Kun-Ming;
    • Chen, Bang-Bin;
    • Chao, Ta-Chung;
    • Huang, Shu-Min;
    • Chang, Dwan-Ying;
    • Chen, I-Chun;
    • Cheng, Ann-Lii;
    • Lu, Yen-Shen
    Publication type:
    Article
    16
    17
    18

    Brain maps of Iowa gambling task.

    Published in:
    2008
    By:
    • Lin CH;
    • Chiu YC;
    • Cheng CM;
    • Hsieh JC;
    • Lin, Ching-Hung;
    • Chiu, Yao-Chu;
    • Cheng, Chou-Ming;
    • Hsieh, Jen-Chuen
    Publication type:
    journal article
    19
    20
    21
    22
    23

    HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis.

    Published in:
    2022
    By:
    • Tan, Ryan Shea Ying Cong;
    • Ong, Whee Sze;
    • Lee, Kyung-Hun;
    • Lim, Abner Herbert;
    • Park, Seri;
    • Park, Yeon Hee;
    • Lin, Ching-Hung;
    • Lu, Yen-Shen;
    • Ono, Makiko;
    • Ueno, Takayuki;
    • Naito, Yoichi;
    • Onishi, Tatsuya;
    • Lim, Geok-Hoon;
    • Tan, Su-Ming;
    • Lee, Han-Byoel;
    • Ryu, Han Suk;
    • Han, Wonshik;
    • Tan, Veronique Kiak Mien;
    • Wong, Fuh-Yong;
    • Im, Seock-Ah
    Publication type:
    journal article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients.

    Published in:
    Breast Cancer Research & Treatment, 2022, v. 192, n. 3, p. 629, doi. 10.1007/s10549-021-06446-7
    By:
    • Lin, Po-Han;
    • Chen, Shin-Cheh;
    • Tseng, Ling-Ming;
    • Chang, King-Jen;
    • Huang, Ai-Chu;
    • Cheng, Kuo-Chih;
    • Yang, Karen;
    • Wu, Hui-Chen;
    • Chao, Tsu-Yi;
    • Chang, Yuan-Ching;
    • Lin, Peng-Chan;
    • Kuo, Wen-Hung;
    • Kuo, Wen-Lin;
    • Lin, Ching-Hung;
    • Chen, Huo-Mu;
    • Yeh, Dah-Cherng;
    • Liu, Liang-Chih;
    • Liu, Chun-Yu;
    • Wang, Ming-Yang;
    • Lo, Chiao
    Publication type:
    Article
    37
    38
    39
    40

    Concurrent epirubicin and trastuzumab use increases complete pathological response rate without additional cardiotoxicity in patients with human epidermal growth factor receptor 2‐positive early breast cancer: A meta‐regression analysis.

    Published in:
    Cancer Medicine, 2024, v. 13, n. 14, p. 1, doi. 10.1002/cam4.70005
    By:
    • Yang, Ming‐Han;
    • Huang, Chiun‐Sheng;
    • Chang, Dwan‐Ying;
    • Hu, Fu‐Chang;
    • Huang, Shu‐Min;
    • Huang, Po‐Hsiang;
    • Chen, I‐Chun;
    • Chen, Tom Wei‐Wu;
    • Lin, Ching‐Hung;
    • Lu, Yen‐Shen
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50